Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03701282 |
|---|---|
| Brief Title: | Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia |
| First Submitted : | October 8, 2018 |
| First Submitted that Met QC Criteria : | October 8, 2018 |
| First Posted : | October 10, 2018 |
| Last Update Submitted that Met QC Criteria : | June 17, 2021 |
| Last Update Posted : | June 18, 2021 (Estimate) |